TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1063-1070

  Kaba, S E ^a   Kyritsis, A P ^a   Hess, K ^a   Yung, W K ^a   Mercier, R ^a   Dakhil, S ^a   Jaeckle, K A ^a   Levin, V A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; HYDROXYUREA; LOMUSTINE; MITOLACTOL; PROCARBAZINE; TIOGUANINE;

ADULT; ARTICLE; BLADDER CANCER; BONE MARROW SUPPRESSION; BRAIN METASTASIS; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; COLON CANCER; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CANCER; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MELANOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0031044739     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1063     Document Type: Article

References (53)

1. Patchell RA: Brain metastases. Neurol Clin 9:817-824, 1991
2. Cairncross JG, Kim J-H, Posner JB: Radiation therapy for brain metastases. Ann Neurol 7:529-541, 1980
3. Posner J, Chernik N: Intracranial metastases from systemic cancer. Adv Neurol 19:579-592, 1978
4. Siegers HP: Chemotherapy for brain metastases: Recent developments and clinical considerations. Cancer Treat Rev 17:63-76, 1990
5. Delattre JY, Krol K, Thaler HT: Distribution of brain metastases. Arch Neurol 45:741-744, 1988
6. Zimm S, Wampler GL, Stablein D: Intracranial metastases in solid tumor patients: Natural history and results of treatment. Cancer 48:384-394, 1981
7. Cho KG, Hoshino T, Pitts LH, et al: Proliferative potential of brain metastases. Cancer 62:512-515, 1988
8. Cairncross JG, Posner JB: The management of brain metastases, in Walker MD (ed): Oncology of the Nervous System. The Hague, The Netherlands, Nijhoff, 1983, pp 341-377
9. Newman SJ, Hansen HH: Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma. Cancer 33:492-496, 1974
10. Hildebrand J, Brihaye J, Wagenknecht L, et al: Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors. Eur J Cancer 11:585-587, 1975
11. Garrett MJ, Hughs HJ, Ryall RD: CCNU in brain tumors. Clin Radiol 26:183-184, 1975
12. Lange OF, Scheef W, Hasse KD: Palliative radio-chemotherapy with ifosfamide and BCNU for breast cancer patients with cerebral metastases. Cancer Chemother Pharmacol 26:78-80, 1990 (suppl)
13. Ushio Y, Arita N, Hayakawa T, et al: Chemotherapy of brain metastases from lung carcinoma: A controlled randomized study. Neurosurgery 28:202-205, 1991
14. Levin VA, Prados MD: Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. J Clin Oncol 10:766-771, 1992
15. Bodell WJ, Morgan WF, Rasmussen J, et al: Potentiation of BCNU-induced cytotoxicity in 9L cells by pretreatment with 6-thioguanine. Biochem Pharmacol 34:515-520, 1985
16. Fujimoto S, Ogawa M, Sakurai Y: Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidyl)methyl 1]-1-(2-chlorethyl)-1-nitrosourea hydrochloride. Cancer Res 42:4079-4085, 1982
17. Hunter KJ, Deen DF, Marton LJ: Differential response to 1,3-bis (2-chlorethyl)-1-nitrosourea in drug-resistant and -sensitive 9L rat brain tumor cells pretreated with alpha-difluoromethylornithine and 6-thioguanine. Int J Cancer 44:658-660, 1989
18. Weinkam RJ, Shiba DA: Metabolic activation of procarbazine. Life Sci 22:937-946, 1978
19. Meer L, Schold SC, Kleihues P: Inhibition of the hepatic O6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agents. Biochem Pharmacol 38:929-934, 1989
20. Institoris E: DNA alkylation sites and cytotoxicity in Yoshida cells treated with bifunctional galactitols, in Petri P, Grassi GG (eds): Current Chemotherapy and Immunotherapy. Washington, DC, American Society of Microbiology, 1982, pp 1378-1380
21. Jarman M, Ross WC: The formation of epoxides from substitute hexitols. Carbohydr Res 9:139-147, 1969
22. Levin VA, Wheeler KT: Chemotherapeutic approaches to brain tumors: Experimental observations with dianhydrogalactitol and dibromodulcitol. Cancer Chemother Pharmacol 8:125-131, 1982
23. Lapis K, Jeney A, Kopper L, et al: Theoretical bases for designing combination therapy with dibromodulcitol (DBD), in Hellman K, Connors TA (eds): Cancer Chemotherapy. New York, NY, Plenum, 1976, pp 37-42
24. Pulst SM, Levin VA, Deen DF: In vitro cytotoxic effects and pharmacokinetics of dibromodulcitol in 9L rat brain tumor cells. Pharmacol Rev 3:302-306, 1986
25. Kobayashi S, Hoshino T: Combined cytotoxic effect of low dose 5-fluorouracil and hydroxyurea on 9L cells in vitro. Cancer Res 43:5309-5313,. 1983
26. Cooper JS, Steinfeld AD, Lerch IA: Cerebral metastases: Value of reirradiation in selected patients. Radiology 174:883-885, 1990
27. Buckner J: Surgery, radiation therapy, and chemotherapy for metastatic tumors to the brain. Curr Opin Oncol 4:518-524, 1992
28. Sundaresan N, Sachdev VP, DiGiacinto GV, et al: Reoperation of brain metastases. J Clin Oncol 6:1625-1629, 1988
29. Sawaya R, Ligon L, Bindal R: Management of metastatic brain tumors. Ann Surg Oncol 1:169-178, 1994
30. Loeffler JS, Kooy HM, Wen PY: The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 8:576-582, 1990
31. Jokura H, Takahashi K, Kayama T, et al: Gamma knife radiosurgery of a series of only minimally selected metastatic brain tumors. Acta Neurochir Suppl (Wien) 62:77-82, 1994
32. Steel GG, Adams K: Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res 35:1530-1535, 1975
33. Buckner JC: The role of chemotherapy in the treatment of patients with brain metastases from solid tumors. Cancer Metastasis Rev 10:335-341, 1991
34. Levin VA, Patlak CS, Landahl HD: Heuristic modeling of drug delivery to malignant brain tumors. J Pharmacokinet Biopharm 8:257-296, 1980
35. Folkman J: The vascularisation of tumors. Sci Am 234:58-64, 1976.
36. Long DM: Capillary ultrastructure in human metastatic brain tumours. J Neurosurg 51:53-58, 1979
37. Levin VA: A pharmacologic basis for brain tumor chemotherapy Semin Oncol 2:57-61, 1975
38. Hasegawa H, Shapiro WR, Posner J: Chemotherapy of experimental metastatic brain tumors in female Wistar rats. Cancer Res 39:2691-2697, 1979
39. Levin VA, Freeman-Dove MA, Landahl H: Permeability characteristics of brain adjacent to tumors in rats. Arch Neurol 32:785-791, 1975
40. Hoang-Xuan K, Delattre JY: Treatment of brain metastases, in Hildebrand J (ed): Management in Neuro-Oncology, Berlin, Germany, Springer-Verlag, 1992, pp 23-39
41. Rosner D, Nemoto T, Lane WW: Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 58:832-839, 1986
42. Boogerd W, Dalesio O, Bais E, et al: Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 69:972-980, 1992
43. Cocconi G, Lottici R, Bisagni G, et al: Combination therapy with platinum and etoposide of brain metastases from breast carcinoma. Cancer Invest 8:327-334, 1990
44. Kristensen CA, Kristjansen PE, Hansen HH: Systemic chemotherapy of brain metastases from small cell lung cancer: A review. J Clin Oncol 10:1498-1502, 1992
45. Twelves CJ, Souhami RL, Harper PG, et al: The response of cerebral metastases in small cell lung cancer to systemic chemotherapy Br J Cancer 61:147-150, 1990
46. Lee JS, Murphy WK, Glisson BS, et al: Primary chemotherapy of brain metastases in small cell lung cancer. J Clin Oncol 7:916-922, 1989.
47. Groen HJM, Smit EF, Haaxma-Reiche H, et al: Carboplatin as second treatment for recurrent or progressive brain metastases from small cell lung cancer. Eur J Cancer 29A:1696-1699, 1993
48. Patchell RA, Cirrincione C, Thaler HT, et al: Single brain metastases: Surgery plus radiation or radiation alone. Neurology 36:447-453, 1986
49. Mandell L, Hilaris B, Sullivan M, et al: The treatment of single cerebral metastases from non oat cell lung carcinoma. Surgery and radiation versus radiation therapy alone. Cancer 58:641-649, 1986
50. Pronzato P, Bruna F, Neri E, et al: Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer. Anticancer Res 15:517-519, 1995
51. Cumin I, Lacroix H, Mahe M, et al: Efficacy of the combination of mitomycin, ifosfamide and cisplatin with irradiation for the treatment of cerebral metastasis in non small cell lung carcinoma [in French]. Bull Cancer (Paris) 82:57-62, 1995
52. Pujol JL, Monnier A, Berille J, et al: Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer. Br J Cancer 69:1136-1140, 1994
53. Jacquillat C, Khayat D, Banzet P, et al: Chemotherapy by fotemustine in cerebral metastasis of disseminated malignant melanoma. Cancer Chemother Pharmacol 25:263-266, 1990